Thorvardur Halfdanarson, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Ipsen​
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novartis
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    ITM Isotopen Technologien Muenchen​
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Crinetics
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Perspective Therapeutics​
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Camurus​
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Abdera Therapeutics​
    Topic:
    Consultancy/Advisory Board/Steering Committees​
    Date added:
    01/07/2025
    Date updated:
    01/07/2025

Pages

Return to Northern California Hematology Oncology Conference: A Tumor Board Case-Based Approach to the Latest Breakthroughs